Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention
Patel, A.A.; White, C.M.; Coleman, C.I.
Connecticut Medicine 71(2): 93-95
2007
ISSN/ISBN: 0010-6178 PMID: 17393902 Document Number: 607680
Document emailed within 1 workday
Related Documents
Li, J.; Liu, Z.; Zhang, S.; Shen, Z.; Fan, Z.; Zeng, Y.; Xie, H.; Wang, C.; Jin, X.; Fang, Q.; Zhu, W. 2015: Activated clotting time post therapeutic anticoagulation with unfractionated heparin in patients undergoing elective percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 43(5): 408-412Tian, F.; Yu, H.; Chen, Y.-d.; Liu, H.-b.; Guo, J.; Sun, Z.-j.; Jin, Q.-h.; Yan, F.; Ma, Y.-l.; Gu, X.-f. 2013: Anticoagulant efficacy and safety of argatroban for patients undergoing elective percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 41(6): 480-483
Lee, M.S.; Rametta, S.; Aragon, J.; Khan, A.; Wilentz, J.; Singh, V.; Levitt, H.; Kamra, A.; Valania, G.; Makkar, R. 2005: New heparin dosing regimen for diabetics undergoing percutaneous coronary intervention Journal of Invasive Cardiology 17(5): 248-250
Gurdogan, M.; Ari, H. 2019: The effect of thyroid functions on contrast-induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention Jpma. Journal of the Pakistan Medical Association 69(10): 1453-1458
Jibran, R.; Khan, J.A.; Hoye, A. 2010: Gender disparity in patients undergoing percutaneous coronary intervention for acute coronary syndromes - does it still exist in contemporary practice? Annals of the Academy of Medicine Singapore 39(3): 173-178
Chen, J-lin.; Chen, J.; Qiao, S-bin.; Guo, Y-lin.; Wu, Y-jian.; Dai, J.; Yuan, J-qing.; Qin, X-wen.; Yang, Y-jin.; Gao, R-lin. 2006: A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease Chinese Medical Journal 119(5): 355-359
Brener, S.J.; Alapati, V.; Benson, M.M.; Chan, D.; Cunn, G.; Khan, S.; Kutkut, I.; Narayanan, C.Arun.; O'Laughlin, J.P.; Sacchi, T.J. 2019: Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry Journal of Invasive Cardiology 31(8): 235-238
Li, Q.; Bai, M.; Wang, D.; Zhang, B.; Yao, S.; Zhang, Z. 2015: Closure of coronary perforation with intracoronary gelation sponge particle injection in 9 patients undergoing percutaneous coronary intervention: case report Zhonghua Xin Xue Guan Bing Za Zhi 43(1): 72-73
Phed-on, U.; Naowapanich, S.; Poolsawat, U.; Nimmannit, A.; Wongpraparut, N. 2011: Benefit of post PCI medical checklist to improve adhering with best practice guidelines in the patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) Journal of the Medical Association of Thailand 94 Suppl. 1: S1-10
Liu, X.M.; Dong, J.Z.; Liu, X.H.; Kang, J.P.; Lü, J.; Zhang, Y.; Luo, T.Y.; Guan, Y.; Dai, T.Y.; Guo, F.; Bai, R.; Du, X.; Ma, C.S. 2017: Association of asymptomatic hyperuricemia with mortality in patients undergoing elective percutaneous coronary intervention Zhonghua Yi Xue Za Zhi 97(7): 508-511
Trisnohadi, H.B. 2005: Rapid hemostasis of arterial puncture sites with Angio-Seal in patients undergoing percutaneous coronary intervention Acta Medica Indonesiana 37(2): 87-90
Liang, Y.; Wang, X.-y.; Niu, J.; Gao, W. 2011: Temporal changes and interaction of serum cytokines in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention Zhonghua Yi Xue Za Zhi 91(12): 819-823
Shen, Q-shan.; Liu, Y-sheng.; Zhu, R.; Fu, D-guan.; Tang, Y-qian.; Tao, H.; Li, S-zhen.; Ye, J-wen. 2005: Effects of fluvastatin on blood levels of inflammatory cytokines in patients with unstable angina undergoing percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 33(4): 320-322
Batra, M.K.; Rizvi, N.H.; Sial, J.A.; Saghir, T.; Karim, M. 2019: Angiographic characteristics and in hospital outcome of young patients, age up to 40 versus more than 40 years undergoing primary percutaneous coronary intervention JPMA. Journal of the Pakistan Medical Association 69(9): 1308-1312
Chen, W.-H.; Lau, C.-P.; Lau, Y.-K.; Ng, W.; Lee, P.-Y.; Yu, C.-M.; Ma, E. 2002: Stable and optimal anticoagulation is achieved with a single dose of intravenous enoxaparin in patients undergoing percutaneous coronary intervention Journal of Invasive Cardiology 14(8): 439-442
Liu, Y.; Liu, Y.; Chen, J.; Chen, J.; Chen, S.; Ye, P.; Tan, N.; Li, H. 2014: The correlation of anemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention Zhonghua Nei Ke Za Zhi 53(3): 168-173
Ren, L.-h.; Peng, J.-j.; Ye, H.-m.; Wang, Z.-y.; Chen, C. 2012: High-dose tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Zhonghua Yi Xue Za Zhi 92(28): 1981-1983
Chong, E.; Shen, L.; Poh, K.K.; Tan, H.C. 2012: Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention Singapore Medical Journal 53(3): 164-169
Ai, H.; Wang, C.-m.; Zhu, X.-l.; Gao, H.; Li, N. 2010: Effect of aspiration of coronary thrombus upon prognosis of patients in primary percutaneous coronary intervention Zhonghua Yi Xue Za Zhi 90(11): 728-731
Shammas, N.W.; Lemke, J.H.; Dippel, E.J.; McKinney, D.E.; Takes, V.S.; Youngblut, M.; Harris, M.; Harb, C.; Kapalis, M.J.; Holden, J. 2003: In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant Journal of Invasive Cardiology 15(5): 242-246